"Leukapheresis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The preparation of leukocyte concentrates with the return of red cells and leukocyte-poor plasma to the donor.
| Descriptor ID |
D007937
|
| MeSH Number(s) |
E02.095.160.570 E02.120.285.570 E02.120.527.570 E05.200.500.363.171.570 E05.242.363.171.570
|
| Concept/Terms |
Leukapheresis- Leukapheresis
- Leukaphereses
- Leukocytopheresis
- Leukocytophereses
- Leukopheresis
- Leukophereses
- Leukocytapheresis
- Leukocytaphereses
Lymphapheresis- Lymphapheresis
- Lymphaphereses
- Lymphocytopheresis
- Lymphocytophereses
- Lymphopheresis
- Lymphophereses
- Lymphocytapheresis
- Lymphocytaphereses
|
Below are MeSH descriptors whose meaning is more general than "Leukapheresis".
Below are MeSH descriptors whose meaning is more specific than "Leukapheresis".
This graph shows the total number of publications written about "Leukapheresis" by people in this website by year, and whether "Leukapheresis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leukapheresis" by people in Profiles.
-
Tanhehco YC, Zantek ND, Alsammak M, Chhibber V, Li Y, Becker J, Wu DW, Foster T, Wehrli G. Vascular access practices for therapeutic apheresis: Results of a survey. J Clin Apher. 2019 Oct; 34(5):571-578.
-
Zhao Y, Ibrahim H, Bailey JA, Linden J, Hickson E, Haynes S, Greene M, Vauthrin M, Weinstein R. Therapeutic plasma exchange performed in tandem with hemodialysis without supplemental calcium in the apheresis circuit. J Clin Apher. 2017 Jun; 32(3):154-157.
-
Galera P, Haynes S, Sulmasy P, Bailey JA, Greene M, Vauthrin M, Brettler D, Liebmann J, Mark Madison J, Weinstein R. Physiological measurements corroborate symptomatic improvement after therapeutic leukapheresis in a pregnant woman with chronic myelogenous leukemia. J Clin Apher. 2016 Aug; 31(4):393-7.
-
Klingemann H, Grodman C, Cutler E, Duque M, Kadidlo D, Klein AK, Sprague KA, Miller KB, Comenzo RL, Kewalramani T, Yu N, Van Etten RA, McKenna DH. Autologous stem cell transplant recipients tolerate haploidentical related-donor natural killer cell-enriched infusions. Transfusion. 2013 Feb; 53(2):412-8; quiz 411.
-
Wright SE, Rewers-Felkins KA, Quinlin IS, Phillips CA, Townsend M, Philip R, Zorsky P, Klug P, Dai L, Hussain M, Thomas AA, Sundaramurthy C. Number of treatment cycles influences development of cytotoxic T cells in metastatic breast cancer patients - a phase I/II study. Immunol Invest. 2010; 39(6):570-86.
-
Gupta S, Zhou P, Hassoun H, Kewalramani T, Reich L, Costello S, Drake L, Klimek V, Dhodapkar M, Teruya-Feldstein J, Hedvat C, Kalakonda N, Fleisher M, Filippa D, Qin J, Nimer SD, Comenzo RL. Hematopoietic stem cell mobilization with intravenous melphalan and G-CSF in patients with chemoresponsive multiple myeloma: report of a phase II trial. Bone Marrow Transplant. 2005 Mar; 35(5):441-7.
-
Cerny J, Slavickova A, Krepelova A, Trneny M, Klener P. Chemotherapy alone may lead to a PCR negative stem cell harvest in transformed lymphoma refractory to rituximab. Haematologica. 2003 Mar; 88(3):ECR06.
-
Szymanski IO, Teno RA, Gandhi JG, Newburger PE. Studies on low-dose hydroxyethyl starch leukapheresis. Rate of elimination of HES in vivo and function of the harvested granulocytes in vitro. Vox Sang. 1984; 47(5):325-9.